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Background: We already reported the preliminary data for the one year clinical impact
of post-procedural incomplete stent apposition (PISA) and late incomplete stent apposi-
tion (LISA) in the newer generation of drug eluting stent. The aim of this study was to
investigate the clinical impact of LISA and PISA during 24-month clinical follow up.
Methods: We prospectively enrolled 178 patients who underwent percutaneous coronary
intervention (PCI) in de novo coronary lesions; stable angina (n41), unstable angina
(n91), and non-ST segment elevation myocardial infarction (n46) (63.79.4 years,
125 male, 187 lesions). The group was randomly assigned (proportion of 1:2) to
everolimus eluting stent (group I, n65, Xience V, Abbott Vascular, Illinois) or
zotarolimmus eluting stent (group II, n122, Endeavor Resolute, Medtronic, MN).
Post-PCI and follow up intravascular ultrasound (IVUS, mean 10.22.9 months) were
performed in all patients. We analyzed 24-month major adverse cardiac events including
death, myocardial infarction (MI) and target lesion failure (TLR).
Results: The Post-PCI external elastic membrane (EEM) volume vs follow up EEM
volume (group I: 368.0169.6 mm3 vs 373.6167.2 mm3, pNS, group II:
431.0167.5 vs 440.1172.0 mm3, pNS), and post-PCI lumen volume vs follow up
lumen volume (group I: 203.086.8 vs 201.786.0 mm3, pNS, group II: 239.292.7
vs 239.592.5 mm3, pNS) by IVUS were not different. There were three LISAs [1.6%,
group I (n1) vs group II (n2)] and sixty four PISAs [34.2%, group I (n24 vs group
II (n40)] that were resolved [12.5%, group I (n2) vs group II (n6)]. Post-PCI and
follow up volume of PISA was not significantly different in both group I (6.44.3 vs
6.33.9 mm3, pNS) and group II (6.45.3 vs 6.24.3 mm3, pNS). Both PISA and
LISA were not related with cardiac death or MI during 24-month clinical follow up.
However, there were four TLRs in PISA subgroup [6.3%, group I (n0) vs group II
(n4)].
Conclusions: The incidence of LISA was low in both groups. Both PISA and LISA were
not related with cardiac death or MI during 24-month clinical follow up. Future long-term
follow up study to clarify the clinical course of LISA and PISA would be needed to
confirm our results.
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Background: Rotational atherectomy (ROTA) is a safe and effective treatment of severe
calcified coronary lesions. It works by differential ablation of the inelastic components of
the atherosclerotic plaque, in particular the calcified areas. However this has never been
characterized in vivo. New tissue characterization techniques coupled with intracoronary
ultrasound (IVUS), like iMap®(BSC, Mn), make this possible.
Methods: We present a prospective study conducted in pts submitted to ROTA under
IVUS guidance using a 40 MHz probe with tissue characterization. Plaque morphology
and composition was assessed pre and post ROTA. All pts had severely calcified coronary
artery disease and an indication for rotablation. After collection, data was sent to an
independent reviewer who was not present during the procedure. Plaque composition was
quantified with QIVUS (Medis) according to percentage fibrotic, lipid, necrotic, calcified
and unknown components.
Results: 20 lesions with an exact landmark matching between basal and post ROTA were
analyzed, after an increment in burr of 0.25-0.50 mm. Luminal area increased on average
0.99  0.82 mm2 due to removal of an average 24.5  12.0% of plaque area. Plaque
composition analysis showed that most of the removed plaque was fibrotic tissue (56%),
followed by calcified (19%) and/or necrotic (18%). Lipid component had little change.
Conclusions: For the first time it was possible to demonstrate in vivo the mechanism of
plaque removal by rotablation. This data confirms the ability of ROTA to remove inelastic
plaque, not only calcified but also fibrotic tissue, which was predominant.
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Background: Several studies have reported that culprit lesion attenuated plaque assessed
by intravascular ultrasound (IVUS) is related to slow/no-reflow after percutaneous
coronary intervention (PCI). Long-term prognostic impact of the culprit lesion attenuated
plaque is unknown.The aim of this study was to investigate acute and long-term clinical
impact of the attenuated plaque in patients with acute coronary syndrome (ACS).
Methods: A total of 110 ACS patients who underwent successful PCI under IVUS
guidance were enrolled and studied. Acute and long-term clinical outcomes were
compared between patients with attenuated plaque (n73) and those without attenuated
plaque (non-attenuated plaque: n37). Long-term cardiac event was defined as a
composite of death and ACS.
Results: Baseline characteristics in 2 groups were similar. Attenuated plaque was
associated with higher TIMI frame count immediate after the first balloon inflation. After
thrombectomy and intracoronary drug administration, final TIMI frame count became
similar between attenuated and non-attenuated plaque. Although attenuated plaque was
associated with higher incidence of fatal arrhythmia during hospitalization, in hospital
mortality did not differ between the 2 groups. During follow-up (median 6.2 years),
cardiac event-free survival was similar between the 2 groups (Figure).
Conclusions: Despite the initial unfavorable effect on coronary reflow, presence of
attenuated plaque did not affect acute as well as long-term clinical outcome in patients
with ACS, possibly as a result of adjunctive pharmacological or aspiration therapies.
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